Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts

Shares of Celcuity Inc. (NASDAQ:CELC - Get Free Report) have been given an average rating of "Buy" by the seven brokerages that are presently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.17.

CELC has been the topic of a number of analyst reports. HC Wainwright reaffirmed a "buy" rating and issued a $27.00 price objective on shares of Celcuity in a research note on Friday, November 15th. Needham & Company LLC upped their price objective on shares of Celcuity from $23.00 to $29.00 and gave the company a "buy" rating in a research note on Thursday, February 6th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CELC. Soleus Capital Management L.P. boosted its stake in Celcuity by 106.0% during the fourth quarter. Soleus Capital Management L.P. now owns 2,565,087 shares of the company's stock worth $33,577,000 after acquiring an additional 1,319,700 shares in the last quarter. Baker BROS. Advisors LP boosted its stake in Celcuity by 42.9% during the fourth quarter. Baker BROS. Advisors LP now owns 2,678,553 shares of the company's stock worth $35,062,000 after acquiring an additional 803,575 shares in the last quarter. State Street Corp boosted its stake in Celcuity by 152.2% during the third quarter. State Street Corp now owns 1,107,415 shares of the company's stock worth $16,512,000 after acquiring an additional 668,318 shares in the last quarter. Janus Henderson Group PLC bought a new position in Celcuity during the fourth quarter worth $8,468,000. Finally, Braidwell LP boosted its stake in Celcuity by 71.2% during the third quarter. Braidwell LP now owns 884,306 shares of the company's stock worth $13,185,000 after acquiring an additional 367,663 shares in the last quarter. 63.33% of the stock is owned by institutional investors.

Remove Ads

Celcuity Trading Up 6.6 %

Shares of NASDAQ:CELC traded up $0.66 during trading on Wednesday, reaching $10.64. The stock had a trading volume of 766,397 shares, compared to its average volume of 266,525. The firm's fifty day moving average is $11.77 and its 200 day moving average is $13.59. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35. Celcuity has a 52 week low of $8.53 and a 52 week high of $22.19. The stock has a market cap of $395.06 million, a price-to-earnings ratio of -4.08 and a beta of 0.73.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.